Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,344,052
-$209,672 QoQ
Shares Held
170,573
+3.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#189
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRUDENTIAL PLC holds $379,910,977 across 10 Drug Manufacturers - General names. AZN ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
400,991 | $101,839,684 | |
| 2 | LLY |
ELI LILLY & Co
|
75,814 | $90,933,592 | |
| 3 | MRK |
Merck & Co., Inc.
|
344,478 | $44,265,422 | |
| 4 | ABBV |
AbbVie Inc.
|
158,913 | $39,988,867 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
170,573 | $32,344,052 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
159,677 | $20,173,592 | |
| 7 | AMGN |
Amgen Inc
|
49,223 | $17,824,631 | |
| 8 | PFE |
Pfizer Inc
|
719,586 | $17,327,630 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,344,052 | 170,573 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $32,553,724 | 165,063 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||